John L. Higgins
2017
In 2017, John L. Higgins earned a total compensation of $5.5M as Chief Executive Officer at Ligand Pharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Non-Equity Incentive Plan | $550,491 |
| Option Awards | $2,202,412 |
| Salary | $611,656 |
| Stock Awards | $2,111,154 |
| Other | $7,494 |
| Total | $5,513,207 |
Higgins received $2.2M in option awards, accounting for 40% of the total pay in 2017.
Higgins also received $30K in bonus, $550.5K in non-equity incentive plan, $611.7K in salary, $2.1M in stock awards and $7.5K in other compensation.
Rankings
In 2017, John L. Higgins' compensation ranked 1,649th out of 14,666 executives tracked by ExecPay. In other words, Higgins earned more than 88.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,649 out of 14,666 | 89th |
Division Manufacturing | 555 out of 5,772 | 90th |
Major group Chemicals And Allied Products | 147 out of 2,075 | 93rd |
Industry group Drugs | 107 out of 1,731 | 94th |
Industry Pharmaceutical Preparations | 85 out of 1,333 | 94th |
Source: SEC filing on April 30, 2018.
Higgins' colleagues
We found three more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2017.